通过第一次排尿捕获的女性生殖道分泌物中的人乳头瘤病毒特异性抗体仍具有中和能力

IF 4.8 4区医学

Human Vaccines & Immunotherapeutics Pub Date : 2024-04-03 DOI:10.1080/21645515.2024.2330168

Laura Téblick, Marijana Lipovac, Freya Molenberghs, Peter Delputte, Winnok H. De Vos, Alex Vorsters

引用次数: 0

摘要

人类乳头瘤病毒 (HPV) 疫苗主要依靠中和抗体，已被证明非常有效。最近，在女性生殖道秒速快三精准人工下注计划中检测到了人乳头瘤病毒特异性抗体。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

HPV-specific antibodies in female genital tract secretions captured via first-void urine retain their neutralizing capacity

Human papillomavirus (HPV) vaccines, primarily relying on neutralizing antibodies, have proven highly effective. Recently, HPV-specific antibodies have been detected in the female genital tract sec...

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY

自引率

8.30%

发文量

审稿时长

1 months

期刊介绍： (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.